XORTX Therapeutics
(NASDAQ:XRTX)
1.32
-0.0043[-0.32%]
At close: May 23
1.34
0.0200[1.52%]
PreMarket: 8:00AM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low0.96 - 8.19
Open / Close- / -
Float / Outstanding12.4M / 13M
Vol / Avg.- / 192.6K
Mkt Cap17.1M
P/E-
50d Avg. Price1.64
Div / Yield-
Payout Ratio-
EPS1.02
Total Float12.4M

XORTX Therapeutics (NASDAQ:XRTX), Quotes and News Summary

XORTX Therapeutics (NASDAQ: XRTX)

Day High/Low- - -
52 Week High/Low0.96 - 8.19
Open / Close- / -
Float / Outstanding12.4M / 13M
Vol / Avg.- / 192.6K
Mkt Cap17.1M
P/E-
50d Avg. Price1.64
Div / Yield-
Payout Ratio-
EPS1.02
Total Float12.4M
XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

Earnings

see more
Q1 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-19
REV
Q4 2021Est.ActualSurprise
EPS0.590
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

XORTX Therapeutics Questions & Answers

Q
How do I buy XORTX Therapeutics (XRTX) stock?
A

You can purchase shares of XORTX Therapeutics (NASDAQ: XRTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are XORTX Therapeutics's (XRTX) competitors?
A

There are no as such competitors for XORTX Therapeutics.

Q
What is the target price for XORTX Therapeutics (XRTX) stock?
A

The latest price target for XORTX Therapeutics (NASDAQ: XRTX) was reported by Alliance Global Partners on Thursday, December 9, 2021. The analyst firm set a price target for 11.00 expecting XRTX to rise to within 12 months (a possible 733.33% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for XORTX Therapeutics (XRTX)?
A

The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $1.32 last updated May 23, 2022, 8:00 PM UTC.

Q
Does XORTX Therapeutics (XRTX) pay a dividend?
A

A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on February 17, 2014 to stockholders of record on January 31, 2014.

Q
When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?
A

XORTX Therapeutics’s Q1 earnings are confirmed for Tuesday, July 19, 2022.

Q
Is XORTX Therapeutics (XRTX) going to split?
A

There is no upcoming split for XORTX Therapeutics.

Q
What sector and industry does XORTX Therapeutics (XRTX) operate in?
A

XORTX Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.